sees fy earnings per share $num-one to $num-two.
sees fy sales $num-one billion to $num-two billion.
qtr-four sales rose 26 percent to $num-one million.
west pharmaceutical services- year-seven net sales guidance includes estimated full-year year-seven headwind of $num-two million based on current foreign exchange rates.
west pharmaceutical services- year-seven net sales guidance includes estimated full-year year-seven headwind of $num-one million based on current foreign exchange rates.